PSTV Stock Analysis: Buy, Sell, or Hold?
PSTV - PLUS THERAPEUTICS, Inc. Common Stock
$0.22
-0.01 (-5.80%)
▼
5d:
-11.32%
30d:
-28.43%
90d:
-62.64%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Get Alerted When PSTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PSTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PSTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PSTV is currently trading at $0.22, which is considered oversold relative to its 30-day fair value range of $0.25 to $0.30.
Technical Outlook: Technically, PSTV is in a strong downtrend. The price is currently testing key support at $0.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: PSTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.30 (+2204.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PSTV is in a strong downtrend. The price is currently testing key support at $0.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: PSTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.30 (+2204.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.25 -
$0.30
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- BULLISH: Trading 2204.3% below Wall St target ($5.30)
- CAUTION: 5-day price weakness (-11.3%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.25 -
$0.30
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.23
Resistance Level
$0.27
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.56
Wall Street Target
$5.30
(+2204.3%)
Revenue Growth (YoY)
-3.2%
Share & Embed Analysis
Last updated: March 30, 2026 9:54 AM ET
Data refreshes hourly during market hours. Next update: 10:54 AM
Data refreshes hourly during market hours. Next update: 10:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PSTV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Andrew John Hugh Macinty…
BUY
20000 shares
2025-11-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 60 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 60 HOLD |
